FFA
BMRN icon

Farther Finance Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Farther Finance Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$509K Buy
8,489
+618
+8% +$38.9K ﹤0.01% 1577
2026
Q2 		$451K Buy
7,871
+14
+0.2% +$767 ﹤0.01% 1634
2026
Q1 		$450K Buy
7,857
+3,484
+80% +$203K ﹤0.01% 1479
2025
Q4 		$260K Buy
4,373
+3,967
+977% +$216K ﹤0.01% 1744
2025
Q3 		$22K Buy
406
+161
+66% +$9.21K ﹤0.01% 2986
2025
Q2 		$13.5K Sell
245
-186
-43% -$11K ﹤0.01% 2915
2025
Q1 		$29.3K Buy
431
+211
+96% +$14.2K ﹤0.01% 2170
2024
Q4 		$14.5K Buy
220
+130
+144% +$8.71K ﹤0.01% 2218
2024
Q3 		$6.33K Buy
90
+2
+2% +$167 ﹤0.01% 2554
2024
Q2 		$7.23K Sell
88
-38
-30% -$3.16K ﹤0.01% 2213
2024
Q1 		$11K Sell
126
-22
-15% -$1.97K ﹤0.01% 1724
2023
Q4 		$14.3K Buy
148
+112
+311% +$9.91K ﹤0.01% 1453
2023
Q3 		$3.19K Sell
36
-9
-20% -$801 ﹤0.01% 1673
2023
Q2 		$3.9K Buy
45
+34
+309% +$3.2K ﹤0.01% 1521
2023
Q1 		$1.07K Hold
11
– – ﹤0.01% 1827
2022
Q4 		$1.14K Buy
+11
New +$1.03K ﹤0.01% 1619

Other funds holding BMRN

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Farther Finance Advisors's BMRN Position: Q3 2026 in Review

Farther Finance Advisors increased its BioMarin Pharmaceuticals (BMRN) stake by 7.9% in Q3 2026, buying an estimated $38.9K and bringing the position to 8,489 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Farther Finance Advisors first reported a position in BMRN in Q4 2022 and has held it in 16 quarters since. 25 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Farther Finance Advisors held 8,489 shares of BioMarin Pharmaceuticals worth $509K as of Q3 2026.
  • Farther Finance Advisors bought 618 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $38.9K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1577 holding.
  • Farther Finance Advisors first reported a position in BioMarin Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • 25 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.